TY - JOUR
T1 - Identifying domains for CNO and SAPHO
T2 - A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group
AU - Oliver, Melissa
AU - Nuruzzaman, Farzana
AU - Lenert, Aleksander
AU - Jayatilleke, Arundathi
AU - Theos, Alexander
AU - Palmou-Fontana, Natalia
AU - Skinner, Alissa
AU - Twilt, Marinka
AU - Wu, Eveline Y.
AU - Aguiar, Cassyanne
AU - Shah, Samir
AU - Romano, Micol
AU - Li, Suzanne
AU - Lapidus, Sivia
AU - King, Jenna
AU - Gerber, Sierra
AU - Welc, Bethany
AU - Bergstrom, Lindsey
AU - Fox, Emily
AU - Hollander, Matthew
AU - Simonini, Gabriele
AU - Alsaleem, Alhanouf
AU - Chan, Karmela Kim
AU - Laxer, Ron
AU - Onel, Karen
AU - Ozen, Seza
AU - Dedeoglu, Fatma
AU - Ferguson, Polly
AU - Helliwell, Philip
AU - Shea, Beverley
AU - Hedrich, Christian
AU - Akikusa, Jonathan
AU - Mease, Philip
AU - Zhao, Yongdong
N1 - Publisher Copyright:
© 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
PY - 2025/12
Y1 - 2025/12
N2 - Introduction: Chronic nonbacterial osteomyelitis (CNO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome are autoinflammatory bone diseases of unknown etiology that present with bone pain and varying degrees of extraosseous manifestations such as skin, intestinal and joint involvement. Currently, there are no validated outcome measurement sets that represent the input from all collaborating groups. Methods: The OMERACT CNO & SAPHO working group performed a scoping review to identify domains previously used in CNO and SAPHO clinical studies. The list of potential domains was narrowed through a process of binning and winnowing. Results: A scoping review included 260 observational studies published from 1978 -2020 and 220 domains were initially identified. Domains were reduced to 25 through a binning and winnowing process. Domains cover each of the OMERACT core with most domains mapped to life impact and pathophysiological manifestations. Conclusion: We identified 25 potential domains covering health concepts of function, disease manifestations, pain, and impact on mental health and societal participation to be included in the final core domain set. The next step will be to reach a consensus on the final CNO & SAPHO core domain set and begin instrument selection.
AB - Introduction: Chronic nonbacterial osteomyelitis (CNO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome are autoinflammatory bone diseases of unknown etiology that present with bone pain and varying degrees of extraosseous manifestations such as skin, intestinal and joint involvement. Currently, there are no validated outcome measurement sets that represent the input from all collaborating groups. Methods: The OMERACT CNO & SAPHO working group performed a scoping review to identify domains previously used in CNO and SAPHO clinical studies. The list of potential domains was narrowed through a process of binning and winnowing. Results: A scoping review included 260 observational studies published from 1978 -2020 and 220 domains were initially identified. Domains were reduced to 25 through a binning and winnowing process. Domains cover each of the OMERACT core with most domains mapped to life impact and pathophysiological manifestations. Conclusion: We identified 25 potential domains covering health concepts of function, disease manifestations, pain, and impact on mental health and societal participation to be included in the final core domain set. The next step will be to reach a consensus on the final CNO & SAPHO core domain set and begin instrument selection.
KW - Autoinflammatory disease
KW - Chronic nonbacterial osteomyelitis
KW - Core domain set
KW - OMERACT
KW - Scoping review
UR - https://www.scopus.com/pages/publications/105024856050
U2 - 10.1016/j.semarthrit.2025.152862
DO - 10.1016/j.semarthrit.2025.152862
M3 - Article
C2 - 41270570
AN - SCOPUS:105024856050
SN - 0049-0172
VL - 75
JO - Seminars in Arthritis and Rheumatism
JF - Seminars in Arthritis and Rheumatism
M1 - 152862
ER -